Ornithine Aspartate and Vitamin-E Combination Has Beneficial Effects on Cardiovascular Risk Factors in an Animal Model of Nonalcoholic Fatty Liver Disease in Rats

Cardiovascular (CV) disease is the main cause of death in nonalcoholic fatty liver disease (NAFLD), a clinical condition without any approved pharmacological therapy. Thus, we investigated the effects of ornithine aspartate (LOLA) and/or Vitamin E (VitE) on CV parameters in a steatohepatitis experim...

Description complète

Détails bibliographiques

Auteurs principaux:	Laura Bainy Rodrigues de Freitas, Larisse Longo, Eduardo Filippi-Chiela, Valessa Emanoele Gabriel de Souza, Luiza Behrens, Matheus Henrique Mariano Pereira, Luiza Cecília Leonhard, Giulianna Zanettini, Carlos Eduardo Pinzon, Eduardo Luchese, Guilherme Jorge Semmelmann Pereira Lima, Carlos Thadeu Cerski, Carolina Uribe-Cruz, Mário Reis Álvares-da-Silva
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2022-11-01
Collection:	Biomolecules
Sujets:	animal model cardiovascular risk nonalcoholic fatty liver disease ornithine aspartate steatohepatitis vitamin E
Accès en ligne:	https://www.mdpi.com/2218-273X/12/12/1773
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!